Recent advances in aerosol devices for the delivery of inhaled medications

References

• Ari A, Restrepo RD. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care. 2012;57(4):613–626.
   PubMed Web of Science ®Google Scholar
• Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377(9770):1032–1045.
   PubMed Web of Science ®Google Scholar
• Dolovich M. Aerosols and aerosol drug delivery systems. In: Adkinson N, Busse W, Bochner B, et al., editors. Middleton’s allergy: principles and practice. 7th ed. Philadelphia(PA): Mosby, Elsevier; 2009. p. 679–700.
   Google Scholar
• Perriello EA, Sobieraj DM. The respimat soft mist inhaler, a novel inhaled drug delivery device. Connecticut Med. 2016;80(6):359–364.
   PubMedGoogle Scholar
• Watts AB, McConville JT, Williams RO 3rd. Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev Ind Pharm. 2008;34(9):913–922.
   PubMed Web of Science ®Google Scholar
• De Boer AH, Hagedoorn P, Hoppentocht M, et al. Dry powder inhalation: past, present and future. Expert Opin Drug Deliv. 2017;14(4):499–512.
   PubMed Web of Science ®Google Scholar
• Rau JL. Practical problems with aerosol therapy in COPD. Respir Care. 2006;51(2):158–172.
   PubMed Web of Science ®Google Scholar
• Ari A, Fink JB. Aerosol delivery devices for the treatment of adult patients in acute and critical care. Curr Pharm Biotechnol. 2016;17(14):1268–1277.
   PubMed Web of Science ®Google Scholar
• Ari A, Fink JB. differential medical aerosol device and interface selection in patients during spontaneous, conventional mechanical and noninvasive ventilation. J Aerosol Med Pulm Drug Deliv. 2016;29(2):95–106.
   PubMed Web of Science ®Google Scholar
• Ari A, Fink J. Guidelines to aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy? Expert Rev Respir Med. 2011;5(4):561–572.
   PubMed Web of Science ®Google Scholar
• Ari A. Jet, mesh and ultrasonic nebulizers: an evaluation of nebulizers for better clinical practice. Eurasian J Pulmonol. 2014;16:1–7.
   Google Scholar
• Carvalho TC, McConville JT. The function and performance of aqueous aerosol devices for inhalation therapy. J Pharm Pharmacol. 2016;68(5):556–578.
   PubMed Web of Science ®Google Scholar
• Taylor K. Ultrasonic nebulizers for pulmonary drug delivery. Int J Pharm. 1997;153:93–104.
   Web of Science ®Google Scholar
• Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5(2):114–119.
   PubMedGoogle Scholar
• Vecellio L. The mesh nebulizer: a recent technical innovation for aerosol delivery. Breathe. 2006;2:253.
   Google Scholar
• Dhand R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care. 2002;47(12):1406–1416.
   PubMedGoogle Scholar
• Parkins MD, Elborn JS. Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis. Expert Rev Respir Med. 2010;4(4):435–444.
   PubMedGoogle Scholar
• Retsch-Bogart GZ, Quittner AL, Gibson RL, et al. Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest. 2009;135(5):1223–1232.
   PubMed Web of Science ®Google Scholar
• Retsch-Bogart GZ, Burns JL, Otto KL, et al. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatr Pulmonol. 2008;43(1):47–58.
   PubMed Web of Science ®Google Scholar
• Galindo-Filho VC, Ramos ME, Rattes CS, et al. Radioaerosol pulmonary deposition using mesh and jet nebulizers during noninvasive ventilation in healthy subjects. Respir Care. 2015;60(9):1238–1246.
   PubMed Web of Science ®Google Scholar
• Ari A, de Andrade AD, Sheard M, et al. Performance comparisons of jet and mesh nebulizers using different interfaces in simulated spontaneously breathing adults and children. J Aerosol Med Pulm Drug Deliv. 2015;28(4):281–289.
   PubMed Web of Science ®Google Scholar
• Alhamad BR, Fink JB, Harwood RJ, et al. Effect of aerosol devices and administration techniques on drug delivery in a simulated spontaneously breathing pediatric tracheostomy model. Respir Care. 2015;60(7):1026–1032.
   PubMed Web of Science ®Google Scholar
• Lin HL, Wan GH, Chen YH, et al. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child. Respir Care. 2012;57(11):1894–1900.
   PubMed Web of Science ®Google Scholar
• Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care. 2004;49(2):174–179.
   PubMedGoogle Scholar
• Ari A, Dang T, Al Enazi FH, et al. Effect of heat moisture exchanger on aerosol drug delivery and airway resistance in simulated ventilator-dependent adults using jet and mesh nebulizers. J Aerosol Med Pulm Drug Deliv. 2017;31(1):42–48.
   Web of Science ®Google Scholar
• Sidler-Moix A, Dolci U, Gryllaki M, et al. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic and mesh nebulizers. Pediatr Crit Care Med. 2013;14(2):1–5.
   PubMed Web of Science ®Google Scholar
• Nakanishi AK, Lamb BM, Foster C, et al. Ultrasonic nebulization of albuterol is no more effective than jet nebulization for the treatment of acute asthma in children. Chest. 1997;111(6):1505–1508.
   PubMed Web of Science ®Google Scholar
• Lin YZ, Huang FY. Comparison of breath-actuated and conventional constant-flow jet nebulizers in treating acute asthmatic children. Acta Paediatr Taiwan. 2004;45(2):73–76.
   PubMedGoogle Scholar
• Berlinski A, Willis JR. Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care. 2013;58(7):1124–1133.
   PubMed Web of Science ®Google Scholar
• Ari A, Atalay OT, Harwood R, et al. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care. 2010;55(7):845–851.
   PubMed Web of Science ®Google Scholar
• Ari A, Areabi H, Fink JB. Evaluation of position of aerosol device in two different ventilator circuits during mechanical ventilation. Respir Care. 2010;55(7):837–844.
   PubMed Web of Science ®Google Scholar
• Denyer J. Adaptive aerosol delivery in practise. Eur Respir Rev. 1997;7:388–389.
   Google Scholar
• Denyer J, Nikander K, Smith N. Adaptive aerosol delivery (AAD) technology. Expert Opin Drug Deliv. 2004;1:165.
   PubMedGoogle Scholar
• Denyer J, Dyche T. The adaptive aerosol delivery (AAD) technology: past, present, and future. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S1–10.
   PubMed Web of Science ®Google Scholar
• Denyer J, Prince I, Dixon E, et al. Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S29–36.
   PubMedGoogle Scholar
• Denyer J, Black A, Nikander K, et al. Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S45–54.
   PubMed Web of Science ®Google Scholar
• Dhand R. Intelligent nebulizers in the age of the internet: the I-neb adaptive aerosol delivery (AAD) system. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):iii–v.
   PubMed Web of Science ®Google Scholar
• Nikander K, Arheden L, Denyer J, et al. Parents’ adherence with nebulizer treatment of their children when using an adaptive aerosol delivery (AAD) system. J Aerosol Med Pulm Drug Deliv. 2003;16(3):273–281.
   Google Scholar
• Nikander K, Prince I, Coughlin S, et al. Mode of breathing-tidal or slow and deep-through the I-neb adaptive aerosol delivery (AAD) system affects lung deposition of (99m)Tc-DTPA. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S37–43.
   PubMed Web of Science ®Google Scholar
• Geller DE, Kesser KC. The I-neb adaptive aerosol delivery system enhances delivery of alpha1-antitrypsin with controlled inhalation. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S55–59.
   PubMed Web of Science ®Google Scholar
• Goodman N, Morgan M, Nikander K, et al. Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S61–70.
   PubMedGoogle Scholar
• Fischer A, Stegemann J, Scheuch G, et al. Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials. Eur J Med Res. 2009;14(Suppl 4):71–77.
   PubMedGoogle Scholar
• Bennett WD. Controlled inhalation of aerosolised therapeutics. Expert Opin Drug Deliv. 2005;2(4):763–767.
   PubMedGoogle Scholar
• Luisetti M, Kroneberg P, Suzuki T, et al. Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer. Pulm Pharmacol Ther. 2011;24(1):123–127.
   PubMed Web of Science ®Google Scholar
• Arnitz R, Stein M, Bauer P, et al. Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study. Ther Adv Respir Dis. 2018;12:1753466618778955.
   Web of Science ®Google Scholar
• van Velzen AJ, Bos AC, Touw DJ, et al. Pharmacokinetics and tolerability of once daily double dose tobramycin inhalation in cystic fibrosis using controlled and conventional nebulization. J Aerosol Med Pulm Drug Deliv. 2016;29(3):273–280.
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, Kardos P, Hofmann T, et al. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. Eur Respir J. 2015;45(5):1273–1282.
   PubMed Web of Science ®Google Scholar
• Luisetti M, Kroneberg P, Suzuki T, et al. Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer. Pulm Pharmacol Ther. 2011;24(1):123–127.
   PubMed Web of Science ®Google Scholar
• Kohler E, Sollich V, Schuster-Wonka R, et al. Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients. J Aerosol Med Pulm Drug Deliv. 2005;18(4):386–395.
   Google Scholar
• Griese M, Ramakers J, Krasselt A, et al. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med. 2004;169(7):822–828.
   PubMed Web of Science ®Google Scholar
• Fink JB, Molloy L, Patton JS, et al. Good things in small packages: an innovative delivery approach for inhaled insulin. Pharm Res. 2017;34(12):2568–2578.
   PubMed Web of Science ®Google Scholar
• Zamanian RT, Levine DJ, Bourge RC, et al. An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension. Pulm Circ. 2016;6(3):329–337.
   PubMed Web of Science ®Google Scholar
• Noymer PD, Myers DJ, Cassella JV, et al. Assessing the temperature of thermally generated inhalation aerosols. J Aerosol Med Pulm Drug Deliv. 2011;24(1):11–15.
   PubMed Web of Science ®Google Scholar
• Dinh K, Myers DJ, Glazer M, et al. In vitro aerosol characterization of Staccato((R)) loxapine. Int J Pharm. 2011;403(1–2):101–108.
   PubMedGoogle Scholar
• Noymer PD, Myers DJ, Cassella JV, et al. Assessing the temperature of thermally generated inhalation aerosols. J Aerosol Med Pulm Drug Deliv. 2011; 24(1): 11-15.
   PubMed Web of Science ®Google Scholar
• Dinh KV, Myers DJ, Noymer PD, et al. In vitro aerosol deposition in the oropharyngeal region for Staccato loxapine. J Aerosol Med Pulm Drug Deliv. 2010;23(4):253–260.
   PubMed Web of Science ®Google Scholar
• Dalby R, Spallek M, Voshaar T. A review of the development of Respimat Soft Mist Inhaler. Int J Pharm. 2004;283(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Stein SW, Thiel CG. The history of therapeutic aerosols: a chronological review. J Aerosol Med Pulm Drug Deliv. 2017;30(1):20–41.
   PubMed Web of Science ®Google Scholar
• Roche N, Dekhuijzen PN. The evolution of pressurized metered-dose inhalers from early To modern devices. J Aerosol Med Pulm Drug Deliv. 2016;29(4):311–327.
   PubMed Web of Science ®Google Scholar
• Newman S. Pressurized metered dose inhalers. In: Dhand R, editor. ISAM textbook. Germany: International Society for Aerosols in Medicine; 2016. pp. 445–467.
   Google Scholar
• Li HY, Xu EY. Innovative pMDI formulations of spray-dried nanoparticles for efficient pulmonary drug delivery. Int J Pharm. 2017;530(1–2):12–20.
   PubMedGoogle Scholar
• Li HY, Zhang F. Preparation of nanoparticles by spray-drying and their use for efficient pulmonary drug delivery. Methods Mol Biol. 2012;906:295–301.
   PubMedGoogle Scholar
• Leach CL. The CFC to HFA transition and its impact on pulmonary drug development. Respir Care. 2005;50(9):1201–1208.
   PubMedGoogle Scholar
• Tinkelman DG, Bleecker ER, Ramsdell J, et al. Proventil HFA and ventolin have similar safety profiles during regular use. Chest. 1998;113(2):290–296.
   PubMed Web of Science ®Google Scholar
• Yang L, da Rocha SR. Understanding solvation in the low global warming hydrofluoroolefin HFO-1234ze propellant. J Phys Chem B. 2014;118(36):10675–10687.
   PubMed Web of Science ®Google Scholar
• Myrdal PB, Sheth P, Stein SW. Advances in metered dose inhaler technology: formulation development. AAPS PharmSciTech. 2014;15(2):434–455.
   PubMed Web of Science ®Google Scholar
• Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med. 2000;94(5):496–500.
   PubMed Web of Science ®Google Scholar
• Price D, Thomas M, Mitchell G, et al. Improvement of asthma control with a breath-actuated pressurised metered dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metered dose inhaler (MDI) or a breath actuated device. Respir Med. 2003;97(1):12–19.
   PubMed Web of Science ®Google Scholar
• Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet. 2004;43(6):349–360.
   PubMed Web of Science ®Google Scholar
• Chen Y, Young PM, Fletcher DF, et al. The influence of actuator materials and nozzle designs on electrostatic charge of pressurised metered dose inhaler (pMDI) formulations. Pharm Res. 2014;31(5):1325–1337.
   PubMed Web of Science ®Google Scholar
• Mitchell JP, Nagel MW. Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. Prim Care Respir J. 2007;16(4):207–214.
   PubMedGoogle Scholar
• Mitchell JP, Coppolo DP, Nagel MW. Electrostatics and inhaled medications: influence on delivery via pressurized metered-dose inhalers and add-on devices. Respir Care. 2007;52(3):283–300.
   PubMed Web of Science ®Google Scholar
• Dompeling E, Oudesluys-Murphy AM, Janssens HM, et al. Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge. Arch Dis Child. 2001;84(2):178–182.
   PubMed Web of Science ®Google Scholar
• Anhoj J, Bisgaard H, Lipworth BJ. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children. Br J Clin Pharmacol. 1999;47(3):333–336.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Calzetta L, Coppola A, et al. Optimizing drug delivery in COPD: the role of inhaler devices. Respir Med. 2017;124:6–14.
   PubMed Web of Science ®Google Scholar
• Nelson HS. Inhalation devices, delivery systems, and patient technique. Ann Allergy Asthma Immunol. 2016;117(6):606–612.
   PubMed Web of Science ®Google Scholar
• Dal Negro RW. Dry powder inhalers and the right things to remember: a concept review. Multidiscip Respir Med. 2015;10(1):13.
   PubMedGoogle Scholar
• Mahler DA, Kerwin E, Ayers T, et al. FLIGHT1 and FLIGHT2: efficacy and safety of QVA149 (Indacaterol/Glycopyrrolate) versus its monocomponents and placebo in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(9):1068–1079.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Arp J, Keegstra JR, et al. Spiromax, a new dry powder inhaler: dose consistency under simulated real-world conditions. J Aerosol Med Pulm Drug Deliv. 2015;28(5):309–319.
   PubMed Web of Science ®Google Scholar
• Azouz W, Chetcuti P, Hosker H, et al. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax(R) and Turbuhaler(R) devices: a randomised, cross-over study. BMC Pulm Med. 2015;15:47.
   PubMed Web of Science ®Google Scholar
• Reid DJ, Carlson AA. Clinical use of aclidinium in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:369–379.
   PubMed Web of Science ®Google Scholar
• Kerwin EM, D’Urzo AD, Gelb AF, et al. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). COPD. 2012;9(2):90–101.
   PubMedGoogle Scholar
• D’Urzo A, Kerwin E, Rennard S, et al. One-year extension study of ACCORD COPD I: safety and efficacy of two doses of twice-daily aclidinium bromide in patients with COPD. COPD. 2013;10(4):500–510.
   PubMedGoogle Scholar
• Rennard SI, Scanlon PD, Ferguson GT, et al. ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients. Clin Drug Investig. 2013;33(12):893–904.
   PubMed Web of Science ®Google Scholar
• Fink JB, Dhand R, Grychowski J, et al. Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med. 1999;159(1):63–68.
   PubMed Web of Science ®Google Scholar
• Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med. 1995;152(4 Pt 1):1391–1394.
   PubMed Web of Science ®Google Scholar
• Ari A. Aerosol drug delivery in critical pulmonary care. Respir Care. 2015;60(6):858–879.
   PubMed Web of Science ®Google Scholar
• Ari A, Fink JB. Factors affecting bronchodilator delivery in mechanically ventilated adults. Nurs Crit Care. 2010;15(4):192–203.
   PubMed Web of Science ®Google Scholar
• Ari A, Fink JB, Dhand R. Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv. 2012;25(6):319–332.
   PubMed Web of Science ®Google Scholar
• Ari A. Aerosol therapy for mechanically ventilated patients: devices, issues, selection & technique. Clin Found. 2012;14:1–12.
   Google Scholar
• Hess D, Fisher D, Williams P, et al. Medication nebulizer performance. effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110(2):498–505.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Braman S, Adams SG, et al. The role of inhalation delivery devices in COPD: perspectives of patients and health care providers. COPD. 2018;5(2):111–123.
   PubMedGoogle Scholar
• Braman SS, Carlin BW, Hanania NA, et al. Results of a pulmonologist survey regarding knowledge and practices with inhalation devices for COPD. Respir Care. 2018;63(7):840–848.
   PubMed Web of Science ®Google Scholar
• Dhand R, Mahler DA, Carlin BW, et al. Results of a patient survey regarding COPD knowledge, treatment experiences, and practices with inhalation devices. Respir Care. 2018;63(7):833–839.
   PubMed Web of Science ®Google Scholar
• Lavorini F, Magnan A, Dubus JC, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593–604.
   PubMed Web of Science ®Google Scholar
• Lavorini F. Inhaled drug delivery in the hands of the patient. J Aerosol Med Pulm Drug Deliv. 2014;27(6):414–418.
   PubMedGoogle Scholar
• Walia M, Paul L, Satyavani A, et al. Assessment of inhalation technique and determinants of incorrect performance among children with asthma. Pediatr Pulmonol. 2006;41(11):1082–1087.
   PubMed Web of Science ®Google Scholar
• Deerojanawong J, Promsaka Na Sakolnakorn V, Prapphal N, et al. Evaluation of metered-dose inhaler administration technique among asthmatic children and their caregivers in Thailand. Asian Pac J Allergy Immunol. 2009;27(2–3):87–93.
   PubMed Web of Science ®Google Scholar
• Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50(10):1360–1374.
   PubMedGoogle Scholar
• Ari A. Patient education and adherence in aerosol therapy. Respir Care. 2015;60(6):941–957.
   PubMed Web of Science ®Google Scholar